凋亡抑制因子Survivin的研究进展(4)
[19] Molckovsky A，Siu L L.First-in-class， first-in-human phase I results of targeted agents：highlights of the 2008 American society of clinical oncology meeting[J].J Hematol Oncol，2008，1：20.
[20] Walker K，Padhiar M.AACR-NCI-EORTC--21st International Symposium[J].Molecular Targets and Cancer Therapeutics—Part 1，2010，13(1)：7-9.
[21] Andersen M H，Svane I M，Becker J C，et al.The universal character of the tumor-associated antigen survivin[J].Clin Cancer Res，2007，13(20)：5991-5994.
[22] Honma I，Kitamura H，Torigoe T，et al.Phase I clinical study of anti-apoptosis protein survivin-derived peptide vaccination for patients with advanced or recurrent urothelial cancer[J].Cancer Immunol Immunother，2009，58(11)：1801-1807.
[23] Kameshima H，Tsuruma T，Kutomi G，et al.Immunotherapeutic benefit of α-interferon(IFNα) in survivin2B-derived peptide vaccination for advanced pancreatic cancer patients[J].Cancer Sci，2013，104(1)：124-129.
[24] Siegel S，Wagner A，Schmitz N，et al.Induction of antitumour immunity using survivin peptide-pulsed dendritic cells in a murine lymphoma model[J].Br J Haematol，2003，122(6)：911-914.
(收稿日期：2017-03-23), 百拇医药(刘馨莲 綦黄鹏 魏仙)
[20] Walker K，Padhiar M.AACR-NCI-EORTC--21st International Symposium[J].Molecular Targets and Cancer Therapeutics—Part 1，2010，13(1)：7-9.
[21] Andersen M H，Svane I M，Becker J C，et al.The universal character of the tumor-associated antigen survivin[J].Clin Cancer Res，2007，13(20)：5991-5994.
[22] Honma I，Kitamura H，Torigoe T，et al.Phase I clinical study of anti-apoptosis protein survivin-derived peptide vaccination for patients with advanced or recurrent urothelial cancer[J].Cancer Immunol Immunother，2009，58(11)：1801-1807.
[23] Kameshima H，Tsuruma T，Kutomi G，et al.Immunotherapeutic benefit of α-interferon(IFNα) in survivin2B-derived peptide vaccination for advanced pancreatic cancer patients[J].Cancer Sci，2013，104(1)：124-129.
[24] Siegel S，Wagner A，Schmitz N，et al.Induction of antitumour immunity using survivin peptide-pulsed dendritic cells in a murine lymphoma model[J].Br J Haematol，2003，122(6)：911-914.
(收稿日期：2017-03-23), 百拇医药(刘馨莲 綦黄鹏 魏仙)